Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment.
Publication
, Journal Article
Kulasingam, SL; Samsa, GP; Matchar, DB
Published in: Am J Alzheimers Dis Other Demen
2006
Duke Scholars
Published In
Am J Alzheimers Dis Other Demen
DOI
ISSN
1533-3175
Publication Date
2006
Volume
21
Issue
2
Start / End Page
73 / 78
Location
United States
Related Subject Headings
- United States
- Randomized Controlled Trials as Topic
- Radiopharmaceuticals
- Positron-Emission Tomography
- Medicare
- Humans
- Health Policy
- Geriatrics
- Fluorodeoxyglucose F18
- Decision Making
Citation
APA
Chicago
ICMJE
MLA
NLM
Kulasingam, S. L., Samsa, G. P., & Matchar, D. B. (2006). Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment. Am J Alzheimers Dis Other Demen, 21(2), 73–78. https://doi.org/10.1177/153331750602100203
Kulasingam, Shalini L., Gregory P. Samsa, and David B. Matchar. “Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment.” Am J Alzheimers Dis Other Demen 21, no. 2 (2006): 73–78. https://doi.org/10.1177/153331750602100203.
Kulasingam SL, Samsa GP, Matchar DB. Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment. Am J Alzheimers Dis Other Demen. 2006;21(2):73–8.
Kulasingam, Shalini L., et al. “Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment.” Am J Alzheimers Dis Other Demen, vol. 21, no. 2, 2006, pp. 73–78. Pubmed, doi:10.1177/153331750602100203.
Kulasingam SL, Samsa GP, Matchar DB. Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment. Am J Alzheimers Dis Other Demen. 2006;21(2):73–78.
Published In
Am J Alzheimers Dis Other Demen
DOI
ISSN
1533-3175
Publication Date
2006
Volume
21
Issue
2
Start / End Page
73 / 78
Location
United States
Related Subject Headings
- United States
- Randomized Controlled Trials as Topic
- Radiopharmaceuticals
- Positron-Emission Tomography
- Medicare
- Humans
- Health Policy
- Geriatrics
- Fluorodeoxyglucose F18
- Decision Making